|
Roldán V, Marín F, Lip GY. Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody. Circ J. 2012;76(8):1826-7. Epub 2012 Jul 29. PubMed PMID: 22785373.
AÑO: 2012; IF: 3.578
|
22785373
|
Roldán V, Marín F, Fernández H, Manzano-Fernandez S, Gallego P, Valdés M, Vicente V, Lip GY. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. Chest. 2013 Jan;143(1):179-84. PubMed PMID: 22722228.
AÑO: 2013; IF: 7.132
|
|
Hernández-Romero D, Marín F, Roldán V, Lip GY. Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients. J Intern Med. 2012 Oct;272(4):409. doi: 10.1111/j.1365-2796.2012.02565.x. Epub 2012 Jul 27. PubMed PMID: 22702474.
AÑO: 2012; IF: 6.455
|
|
Roldán V, Marín F, Díaz J, Gallego P, Jover E, Romera M, Manzano-Fernández S, Casas T, Valdés M, Vicente V, Lip GY. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost. 2012 Aug;10(8):1500-7. doi: 10.1111/j.1538-7836.2012.04812.x. PubMed PMID: 22681487.
AÑO: 2012; IF: 6.081
|
|
Roldán V, Marín F. Oral anticoagulation in chronic kidney disease: A huge challenge. Thromb Haemost. 2012 Jul;108(1):3-5. doi: 10.1160/TH12-05-0324. Epub 2012 May 25. PubMed PMID: 22628077.
AÑO: 2012; IF: 6.094
|